Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News PTC Therapeutics secures Russian approval for Translarna to treat Duchenne muscular dystrophy PTC Therapeutics, a leading US-based biotechnology company, has received marketing approval in Russia for its innovative drug, Translarna… bypharmanewsdailyDecember 6, 2020